Background: Lacunar infarctions account for up to 25% of all ischemic strokes and, thus, constitute a numerically important subgroup. It is important that the two pathogeneses of lacunar infarction, that is, small-vessel occlusion and branch atheromatous disease, be differentiated because prognoses and treatment strategies differ. The authors evaluated the presence of branch atheromatous plaque in parent arteries that supply lacunar infarcts by high-resolution magnetic resonance imaging (HR-MRI). Methods: HR-MRI was performed in 15 patients with (1) a clinical presentation consistent with classical lacunar syndromes; (2) an acute lacunar infarction by diffusion-weighted imaging, measuring ≤20 mm in maximal diameter; (3) a magnetic resonance angiography showing a normal middle cerebral artery or basilar artery supplying the ischemic lesion, and (4) no other obvious etiology for small-vessel distribution ischemic stroke. Results: The median time of vessel wall imaging after index events was 4 days (range, 2–15 days). Six of the 15 patients had a lacunar infarction in the middle cerebral artery territory, and 9 had a lesion in the basilar artery territory. HR-MRI detected underlying atheromatous plaques in 9 patients (60%) with a lacunar infarction. In these 9 patients, asymptomatic intracranial atherosclerotic stenosis was more frequent compared to patients without branch atheromatous plaque (55.6 vs. 16.7%). In pontine infarctions, ischemic lesions that extended to the pial base of the pons were more frequent in patients with branch atheromatous plaques (83.3 vs. 33.3%), and all the ischemic lesions and atheromatous plaques were on the same side (right, n = 2; left, n = 4). All plaques responsible for acute symptomatic lacunar infarction were enhanced in contrast-enhanced T1-weighted HR-MR images. Conclusions: HR-MRI results enabled underlying symptomatic branch atheromatous disease to be detected in lacunar infarction patients. The experience gained during this study indicates that HR-MRI better delineates intracranial arterial lesions, suggesting that its use will lead to a further understanding of the mechanisms involved in stroke.

Lacunar infarcts are small lesions located in basal ganglia, deep hemispheric white matter, or the brain stem, and are referred to as ‘small deep infarcts’. These lesions are ≤20 mm in maximal diameter and are attributable to occlusion of a single perforating artery [1]. The presence of an occluded perforating artery related to a small deep infarct was first described by Fisher [2]. Furthermore, lacunar infarction is being increasingly recognized as an important stroke subtype due to its clinical implications regarding management and prognosis [3,4].

Most perforating artery occlusions are considered to be caused by a process of arterial disorganization similar to that of lipohyalinosis, or in the acute stage to fibrinoid necrosis [5]. Few occluded perforating arteries have ever been observed pathologically. However, patients rarely expire soon after lacunar stroke and, thus, occluded arteries may recanalize before necropsy [3]. Small subcortical infarcts can be caused by in situ thrombosis of parent arteries that block penetrating branches, by parent artery atheromas that encroach on the orifice of the perforating artery [6], or proximal sources of embolism, such as cardioembolism or carotid artery atherosclerosis [7]. The relative importance of these mechanisms has been much debated, largely in view of the difficulties of identifying perforating artery occlusions during life. Nevertheless, to determine optimal strategies for secondary stroke prevention, the precise differentiation of underlying pathologies of lacunar infarction is an important issue.

Recent studies have reported that high-resolution magnetic resonance imaging (HR-MRI) can be used to study the morphology of intracranial artery vessels, including atherosclerotic plaque [8], irregular wall thickening [9], arterial remodeling [10], and intraplaque hemorrhage [11]. However, it has not been determined whether HR-MRI can identify early-stage atherosclerotic plaque occluding the orifice of a perforating artery in patients with normal magnetic resonance angiography (MRA) findings. Accordingly, our aim was to investigate the wall imaging findings of middle cerebral artery (MCA) and basilar artery (BA) in patients with a lacunar infarction suspected of having small-vessel occlusions.

The medical records of patients admitted to our stroke unit, a comprehensive stroke center in a tertiary hospital, who underwent HR-MRI were reviewed. These files contained data on 50 patients that registered from March 22, 2011, to August 24, 2011. Inclusion criteria for the present study were (1) a clinical presentation consistent with one of the classical lacunar syndromes described by Fisher [12]; (2) an acute lacunar infarction by diffusion-weighted (DW) imaging, measuring ≤20 mm in maximal diameter, in the corona radiata, basal ganglia, internal capsule, or pons; (3) an MRA showing a normal MCA or BA supplying the ischemic lesion, and (4) no other obvious etiology for small-vessel distribution ischemic stroke (e.g. no primary vasculitis, active amphetamine use, or cardiac disease with strong embolic potential). This study was approved by our institutional review board, and all diagnostic modalities were performed after obtaining informed consent.

All 15 patients were imaged using a 3.0-tesla MR scanner (Verio; Siemens Medical Solution, Erlangen, Germany) equipped with a 32-channel head coil. Conventional MRI protocols included a complete set of DW images, T1- and T2-weighted images, fluid-attenuated inversion recovery images, T2* gradient-echo images, and contrast-enhanced MRA images of intracranial and extracranial arteries. HR-MRI was performed on the parent artery supplying lacunar infarction lesions. Maximum intensity projection images and source images of 3D time-of-flight MRA (used as topograms) were used to ensure that cross-section images were perpendicular to infarction locations. Four different types of contrast-weighted images [T1-weighted, T2-weighted, proton density (PD), and contrast-enhanced T1 (T1E)-weighted] were obtained. The parameters of the imaging sequences were as follows: (1) T1-weighted, turbo spin-echo [repetition time (TR)/echo time (TE), 600/12 ms; field of view (FOV), 12 cm; matrix size, 384/219; slice thickness, 2 mm; number of excitations (NEX), 4]; (2) turbo spin-echo PD-weighted imaging (TR/TE, 2,910/23 ms; FOV, 12 cm; matrix size, 384/269; slice thickness, 2 mm; NEX, 4), and (3) turbo spin-echo T2-weighted images (TR/TE, 2,910/70 ms; FOV, 12 cm; matrix size, 384/269; slice thickness, 2 mm; NEX, 4). The non-phase-wrap technique was used to avoid aliasing. Images were interpreted by consensus between board-certified neuroradiologists (C.H. Sohn) and experienced neurologists specializing in stroke (J.-W. Chung and S.-H. Lee) based on HR-MRI findings and medical records.

The ages of the 15 patients ranged from 38 to 85 years (median 69 years), and 9 were men (table 1). Hypertension was the most common risk factor; 4 patients had a stroke history. In all patients, MRA showed a normal MCA or BA proximal to the ischemic lesion. The median time of vessel wall imaging after index events was 4 days (range, 2–15 days). Six of the 15 patients (patients 1–6) had a lacunar infarction in the MCA territory, and 9 (patients 7–15) had a lesion in the BA territory. Three patients had a corona radiata lesion (patients 1, 2, and 6), 2 involved basal ganglia (patients 3 and 5), 1 the internal capsule (patient 4) and 9 the pons (patients 7–15). Among the 15 patients, 8 had a history of a pure motor stroke, 5 of a sensory motor stroke, 1 of dysarthria clumsy hand syndrome, and 1 of ataxic hemiparesis. Of the 6 patients with MCA territory lacunar infarction, HR-MRI showed atherosclerotic plaques in the parent artery in 3 patients, which were located at the ventral (n = 2) and superior (n = 1) aspects of the vessel wall (fig. 1). In 9 patients with a BA territory lacunar infarction, 6 had atherosclerotic plaques in the parent artery, 3 in the ventrolateral, and 3 in the lateral aspect of the vessel wall (fig. 2). For BA territory lacunar infarctions, ischemic lesions extending to the pial surface of the pontine base were more frequent in patients with branch atheromatous plaques (83.3 vs. 33.3%), and all lesions and atheromatous plaques were on the same side (right, n = 2; left, n = 4). Enhancement of underlying atherosclerotic plaques was observed in all 9 patients with parent artery plaques. Asymptomatic intracranial atherosclerotic stenosis was found in 5 patients (55.6%) with branch atheromatous plaque and in 1 patient (16.7%) with no evidence of branch atheromatous plaque. The imaging findings of patients without branch atheromatous disease are shown in figure 3. Imaging study results are described in table 2.

Table 1

Baseline characteristics

Baseline characteristics
Baseline characteristics
Table 2

Imaging studies results

Imaging studies results
Imaging studies results
Fig. 1

Imaging findings of 3 patients with branch atheromatous MCA plaques. a Patient 4: DW image with a focal high signal intensity lesion in the internal capsule, MRA without significant stenosis in the MCA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at ventral MCA with subtle enhancement. b Patient 5: DW image with a focal lesion in basal ganglia, normal MCA by MRA, and T1, T2, PD, and T1E images showing atheromatous plaque at the superior MCA with enhancement. c Patient 6: DW image with a focal corona radiata lesion, normal MCA by MRA, and T1, T2, PD, and T1E images showing atheromatous plaque at the ventrosuperior portion of the MCA with enhancement.

Fig. 1

Imaging findings of 3 patients with branch atheromatous MCA plaques. a Patient 4: DW image with a focal high signal intensity lesion in the internal capsule, MRA without significant stenosis in the MCA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at ventral MCA with subtle enhancement. b Patient 5: DW image with a focal lesion in basal ganglia, normal MCA by MRA, and T1, T2, PD, and T1E images showing atheromatous plaque at the superior MCA with enhancement. c Patient 6: DW image with a focal corona radiata lesion, normal MCA by MRA, and T1, T2, PD, and T1E images showing atheromatous plaque at the ventrosuperior portion of the MCA with enhancement.

Close modal
Fig. 2

Image findings of 6 patients with branch atheromatous plaque in the BA. a Patient 10: DW image showing a high signal intensity lesion in the right pons extending to the base surface, MRA showing no significant stenosis in the BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the ventrolateral portion of the BA with enhancement. b Patient 11: DW image showing a focal lesion in the right pons extending to the base surface, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the lateral BA with enhancement. c Patient 12: DW image showing a focal lesion in the left pons extending to the base surface, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the dorsolateral BA encroaching a perforating artery orifice with enhancement. d Patient 13: DW image showing a high signal intensity lesion in the left pons extending to the base surface, MRA showing no significant stenosis in the BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the ventrolateral BA with enhancement. e Patient 14: DW image showing a focal isolated lesion in the left pons, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating small atheromatous plaque at the lateral BA with enhancement. f Patient 15: DW image showing a focal lesion in left pons extending to the base surface, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the dorsolateral BA with enhancement.

Fig. 2

Image findings of 6 patients with branch atheromatous plaque in the BA. a Patient 10: DW image showing a high signal intensity lesion in the right pons extending to the base surface, MRA showing no significant stenosis in the BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the ventrolateral portion of the BA with enhancement. b Patient 11: DW image showing a focal lesion in the right pons extending to the base surface, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the lateral BA with enhancement. c Patient 12: DW image showing a focal lesion in the left pons extending to the base surface, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the dorsolateral BA encroaching a perforating artery orifice with enhancement. d Patient 13: DW image showing a high signal intensity lesion in the left pons extending to the base surface, MRA showing no significant stenosis in the BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the ventrolateral BA with enhancement. e Patient 14: DW image showing a focal isolated lesion in the left pons, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating small atheromatous plaque at the lateral BA with enhancement. f Patient 15: DW image showing a focal lesion in left pons extending to the base surface, MRA showing a normal BA, and T1, T2, PD, and T1E images demonstrating atheromatous plaque at the dorsolateral BA with enhancement.

Close modal
Fig. 3

Imaging findings of 6 patients without branch atheromatous plaque in the MCA or BA. a–c Patients 1–3: DW images showing a focal high signal intensity lesion in the right corona radiata, left corona radiate, and left basal ganglia, and MRA showing a normal MCA. d–f Patients 7–9: DW image showing a focal isolated lesion in the right pons, left pons, and right pons extending to the basal surface, and an MRA showing no significant stenosis in the BA. All HR-MRI sequence, T1, T2, PD, and T1E images demonstrating normal vessel walls without enhancement.

Fig. 3

Imaging findings of 6 patients without branch atheromatous plaque in the MCA or BA. a–c Patients 1–3: DW images showing a focal high signal intensity lesion in the right corona radiata, left corona radiate, and left basal ganglia, and MRA showing a normal MCA. d–f Patients 7–9: DW image showing a focal isolated lesion in the right pons, left pons, and right pons extending to the basal surface, and an MRA showing no significant stenosis in the BA. All HR-MRI sequence, T1, T2, PD, and T1E images demonstrating normal vessel walls without enhancement.

Close modal

In a previous study performed in the USA, stenotic lesions in large arteries were found in 10% of patients with a lacunar infarction [13], and in a Korean study, 36% of patients with striatocapsular area lacunar infarctions had stenotic MCA lesions [14]. In these studies, MRA and digital subtraction angiography were used to evaluate the presence of parent artery stenosis. However, MRA and digital subtraction angiography cannot identify branch atheromatous disease, occlusion of the perforating artery by an artery-to-artery embolism or a microembolism from atherosclerotic parent artery plaques. Microatheromas, which have been reported to be the most common underlying mechanism of symptomatic lacunar infarction in autopsy studies [2,6], may not be accompanied by significant stenosis in classic luminographic angiography studies. In the present study, HR-MRI performed during the acute period of lacunar infarction showed a surprisingly high prevalence of parent artery branch atheromatous plaques.

Age, hypertension, and diabetes mellitus have been reported to be independent risk factors of intracranial atherosclerotic disease [15]. Other studies have also suggested that intracranial atherosclerotic disease is more common in men, particularly in younger men [16,17]. Furthermore, intracranial atherosclerosis is more common in Asians than Caucasians [18,19,20]. Considering risk factors and ethnic diversities, some individuals are more prone to intracranial atherosclerotic disease. Intracranial atherosclerosis is often progressive, and the degree of stenosis often increases and plaques can ulcerate and promote the formation of platelet-rich and red-cell-rich thrombi. In the present study, asymptomatic intracranial atherosclerotic stenosis was more common in patients with branch atheromatous plaques that caused lacunar infarction. In patients with asymptomatic intracranial atherostenosis and lacunar infarcts, branch atheromatous disease is the likely cause of perforating territory infarcts.

The location of infarction on DW MRI has been posited to separate branch atheromatous disease from intrinsic disease of penetrating arteries. Patients with MCA disease tend to have larger and lower lesion patterns beginning from the proximal territory of the lenticulostriate artery [21]. In BA territory lacunar infarction, paramedian pontine and small deep pontine lesions were found to be no different in terms of the prevalence of branch atheromatous plaques (61.5 and 73%, respectively) [21]. In the present study, pontine lesions that extended to the ventral basal surface were more often caused by branch atheromatous plaques than isolated lacunar infarcts within the pons that did not extend to the pial basal surface. This finding concurs with those reported by Fisher and Caplan [22 ]in 1971 in an autopsy study.

The results of the present study should be interpreted with caution. First, because all patients survived with few neurologic deficits, atherosclerotic plaques that occluded perforating arteries were not confirmed by histopathological study. We did try to visualize the orifices of occluded perforating arteries, but only in 1 patient (patient 12) did we observe plaque protruding toward the orifice of a perforating artery. However, in 6 patients with atherosclerotic BA plaque, all plaques were on the same side as ischemic lesions and at the same level of ischemic lesions visualized by PD HR-MRI. Second, HR-MRI resolution was not sufficient to provide information on plaque composition or whether or not plaques qualified as ‘vulnerable’. However, all atherosclerotic plaques showed contrast medium enhancement. In a recent study, enhancement of MCA atherosclerosis was found to be associated with a history of a symptomatic recent ischemic stroke [23]. Therefore, enhancement of atherosclerotic plaque in our study, imaged during the acute period of ischemic stroke, may indicate that these plaques were vulnerable. Finally, this study was conducted in a retrospective manner based on reviews of electronic medical charts and only 15 patients were included. Future studies with a prospective, consecutive design will be able to further address issues discussed in this study.

In the present study, by using HR-MRI, we were able to visualize branch atheromatous plaques in patients suspected of having small-vessel occlusions. Branch atheromatous disease was frequently observed even in patients with normal parent arteries by MRA. Our experiences indicate that HR-MRI will aid in vivo investigations on intracranial arterial disease and on the elucidation of stroke mechanisms.

This research was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (No. A111014) and by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (No. 2011-0026315). The funders played no role in study design, data collection or analysis, the decision to publish, or in the preparation of the manuscript.

1.
Fisher CM: Lacunes: small, deep cerebral infarcts. Neurology 1965;15:774–784.
2.
Fisher CM: The arterial lesions underlying lacunes. Acta Neuropathol 1968;12:1–15.
3.
Bamford J, Sandercock P, Jones L, Warlow C: The natural history of lacunar infarction: the Oxfordshire community stroke project. Stroke 1987;18:545–551.
4.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
5.
Challa VR, Bell MA, Moody DM: A combined hematoxylin-eosin, alkaline phosphatase and high-resolution microradiographic study of lacunes. Clin Neuropathol 1990;9:196–204.
6.
Fisher CM: Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979;36:65–73.
7.
Kang DW, Chalela JA, Ezzeddine MA, Warach S: Association of ischemic lesion patterns on early diffusion-weighted imaging with toast stroke subtypes. Arch Neurol 2003;60:1730–1734.
8.
Klein IF, Lavallee PC, Touboul PJ, Schouman-Claeys E, Amarenco P: In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology 2006;67:327–329.
9.
Ryu CW, Jahng GH, Kim EJ, Choi WS, Yang DM: High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis 2009;27:433–442.
10.
Ma N, Jiang WJ, Lou X, Ma L, Du B, Cai JF, Zhao TQ: Arterial remodeling of advanced basilar atherosclerosis: a 3-tesla MRI study. Neurology 2010;75:253–258.
11.
Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI: Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging 2011;21:e159–e161.
12.
Fisher CM: Lacunar strokes and infarcts: a review. Neurology 1982;32:871–876.
13.
Sweeny R CE, Kidwell CS, Saver JL: Incidence of intracranial large vessel disease in patients with radiologic lacunar stroke. Neurology 1999;52(suppl 2):A557–A558.
14.
Bang OY, Heo JH, Kim JY, Park JH, Huh K: Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol 2002;59:259–263.
15.
Bae HJ, Lee J, Park JM, Kwon O, Koo JS, Kim BK, Pandey DK: Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis 2007;24:355–360.
16.
Moossy J: Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke 1993;24:I22–I23; I31– I32.
17.
Passero S, Rossi G, Nardini M, Bonelli G, D’Ettorre M, Martini A, Battistini N, Albanese V, Bono G, Brambilla GL, et al: Italian multicenter study of reversible cerebral ischemic attacks. Part 5. Risk factors and cerebral atherosclerosis. Atherosclerosis 1987;63:211–224.
18.
Kappelle LJ, Koudstaal PJ, van Gijn J, Ramos LM, Keunen JE: Carotid angiography in patients with lacunar infarction. A prospective study. Stroke 1988;19:1093–1096.
19.
Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W: Atherosclerotic disease of the middle cerebral artery. Stroke 1986;17:1112–1120.
20.
Thajeb P: Large vessel disease in Chinese patients with capsular infarcts and prior ipsilateral transient ischaemia. Neuroradiology 1993;35:190–195.
21.
Klein IF, Lavallee PC, Mazighi M, Schouman-Claeys E, Labreuche J, Amarenco P: Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke 2010;41:1405–1409.
22.
Fisher CM, Caplan LR: Basilar artery branch occlusion: a cause of pontine infarction. Neurology 1971;21:900–905.
23.
Vergouwen MD, Silver FL, Mandell DM, Mikulis DJ, Swartz RH: Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol 2011;68:338–342.
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.